What Does SS-31 Peptide Do?

SS-31 peptide, also called elamipretide or MTP-131, is a mitochondria-targeted tetrapeptide that binds to cardiolipin on the inner mitochondrial membrane. Its main reported action is to stabilize mitochondrial structure, support electron transport chain efficiency, and reduce reactive oxygen species. SS-31 is not FDA-approved for human use in the United States, so it remains an investigational compound studied in laboratory and clinical research.

What Is SS-31 Peptide and How Does It Work?

SS-31 is a synthetic four-amino-acid peptide with a sequence designed to concentrate inside mitochondria. It belongs to a class of compounds called mitochondria-targeted peptides.

The peptide binds cardiolipin, a phospholipid found almost exclusively on the inner mitochondrial membrane. Cardiolipin helps organize the cristae and supports the supercomplexes that carry out oxidative phosphorylation.

When cardiolipin is damaged by oxidative stress, mitochondria lose efficiency and leak more free radicals. SS-31 appears to protect cardiolipin from peroxidation, which helps mitochondria produce ATP more cleanly.

SS-31 is often described as a mitochondrial antioxidant, but its primary mechanism is structural and energetic rather than a direct free-radical scavenger.

Reported Effects of SS-31 in Research Studies

Most SS-31 research focuses on conditions involving mitochondrial dysfunction. The table below summarizes reported findings and the strength of evidence as of 2025.

Research Area	What Studies Suggest	Evidence Level
Cardiac ischemia-reperfusion	Reduced infarct size and improved recovery in animal models	Preclinical
Heart failure	Improved diastolic function and exercise capacity in early human trials	Early clinical
Barth syndrome	Mixed results; FDA declined approval in 2024	Clinical trials completed
Primary mitochondrial myopathy	Some secondary endpoint improvements, primary endpoint missed	Clinical trials completed
Dry age-related macular degeneration	Ongoing research into retinal cell protection	Clinical trials
Aging and sarcopenia	Improved mitochondrial function in aged animal tissue	Preclinical

These findings are promising but not definitive. No large, confirmatory trial has shown that SS-31 treats or prevents any human disease.

SS-31 vs. Other Peptides: Different Mechanisms, Different Goals

SS-31 is often mentioned alongside peptides that have completely different targets. Understanding the difference helps prevent confusion.

Peptide	Primary Target	Main Research Interest
SS-31 (elamipretide)	Inner mitochondrial membrane cardiolipin	Mitochondrial energy and oxidative stress
BPC-157	Growth factor signaling and tissue repair pathways	Gut lining, tendon, and muscle healing models
TB-500 (thymosin beta-4 fragment)	Actin regulation and cell migration	Wound healing and flexibility models
Collagen peptides	Amino acid supply for connective tissue	Skin elasticity and joint comfort
GLP-1 receptor agonists	Incretin receptors	Blood sugar and appetite regulation

For example, what does glucagon-like peptide 1 do centers on insulin release and appetite signaling, while SS-31 targets mitochondrial energy production. People also ask what does collagen peptide do for skin and joints, but collagen peptides work through amino acid building blocks, not mitochondrial cardiolipin.

SS-31 Peptide Dosing and Administration in Research

Research on ss-31 peptide dosing is not standardized. Animal studies commonly use 1 to 5 mg/kg per day, while human trials have tested elamipretide at doses such as 40 mg subcutaneously once daily or as intravenous infusions.

These doses are for research protocols only. They are not a recommendation for self-administration, and human dosing should only be decided by a licensed healthcare professional in a clinical trial setting.

SS-31 is usually supplied as a lyophilized powder. If you are learning how to reconstitute lyophilized powder, what does bac water do for peptides is a common starting question, but sterile technique and proper storage matter just as much.

Researchers typically store the powder at -20°C, protect it from light, and avoid repeated freeze-thaw cycles after reconstitution.

Safety, Side Effects, and Legal Status

SS-31 is not FDA-approved for any human use in the United States. It is available legally only as a research chemical, not as a prescription medicine or dietary supplement.

In completed clinical trials, reported side effects included injection site reactions, headache, nausea, and dizziness. Most were mild to moderate, but long-term safety data are limited.

Because SS-31 affects mitochondrial function, it could interact with other treatments or have unpredictable effects in people with certain health conditions. Anyone considering it should consult a healthcare professional first.

If you search ss-31 peptide buy online usa, you will find many vendors, but most sell it for laboratory research only. Purity, sterility, and accurate labeling are not guaranteed by the FDA for these products.

How to Evaluate SS-31 Research and Products

• Check for a certificate of analysis (COA) with HPLC purity above 98% and mass spectrometry confirmation.
• Look for third-party testing from an ISO-accredited laboratory.
• Confirm the vendor uses cold-chain shipping and provides storage instructions.
• Read the original research rather than relying on marketing claims.
• Remember that the phrase research use only means the product is not intended for human consumption.

SS-31 is an investigational peptide, not a proven therapy. The same caution applies to any peptide marketed with dramatic before-and-after claims.

Bottom Line

SS-31 peptide targets cardiolipin on the inner mitochondrial membrane to support mitochondrial structure and energy production. Research suggests it may help in conditions linked to mitochondrial dysfunction, but clinical results have been mixed and no approval exists for human use.

Elamipretide is the generic name for SS-31 peptide. If you are considering it for any health purpose, talk with a healthcare professional and rely on peer-reviewed evidence, not vendor claims.

COMMON QUESTIONS

Frequently Asked Questions

What is SS-31 peptide used for?

SS-31 peptide is studied for conditions linked to mitochondrial dysfunction, including heart failure, Barth syndrome, primary mitochondrial myopathy, and dry age-related macular degeneration. It is not approved to treat, cure, or prevent any disease. All current uses are limited to laboratory research or clinical trials.

Is SS-31 peptide safe?

In completed human trials, SS-31 (elamipretide) caused mostly mild side effects such as injection site reactions, headache, and nausea. Long-term safety data are limited. SS-31 is not FDA-approved, and research chemicals should not be used for human consumption outside a supervised clinical trial.

How is SS-31 peptide dosed in research?

Animal studies often use 1 to 5 mg/kg per day, while human trials have tested 40 mg subcutaneously daily or intravenous infusions. Dosing varies by study and condition. There is no standard or approved human dose, so anyone interested should consult a healthcare professional.